IVREA Pharmaceuticals raises $11,000,000

IVREA Pharmaceuticals, an emerging specialty pharmaceutical company focusing on dermatology, today announced it raised $11 million from existing investors Atlas Venture and Easton Capital and new investor CHL Medical Partners. IVREA Pharmaceuticals is developing products having significant medical and patient advantages in the treatment of onychomycosis and acne.